NEW YORK (GenomeWeb) – Invitae has launched its initial public offering at $16 per share.

The San Francisco-based molecular diagnostics firm offered 6,350,000 shares of its common stock, bringing in gross proceeds of $101.6 million. It also has granted the underwriters a 30-day option to purchase up to an additional 952,500 shares.

The offering price is above a range of $13 to $15 per share put forth in a preliminary prospectus filed two weeks ago. It also increased the number of shares offered from a previous expectation of 5,350,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.